Safety and Feasibility of imILT Locally Advanced Pancreatic Cancer (LAPC)


NCT02702986

Interventional

Phase 1

Completed
10 Patients with Locally Advanced Pancreatic Cancer, no further responsive to neoadjuvant treatments but with a Stage-III disease will be submitted to imILT (Immunostimulating Interstitial Laser Thermotherapy). Safety and feasibility of imILT on LAPC will be evaluated as primary objective. Secondary objectives will be QoL after imILT, study of the immune reaction after imILT, oncological analysis of patients suffering from LAPC submitted to imILT.
More informations
Feb 29,2016
All
18 Years
85 Years
10